Logo
I

ImaginAb

29 employees

ImaginAb clinically manages cancer and autoimmune diseases via molecular imaging by re-engineering antibodies into small proteins.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
cancer
Minibody
Immunocology
Personalized medicine
CD8 Tracer
Biomarker
Health Diagnostics
PET Imaging
Health Care
Oncology
Antibody engineering and imaging
Therapeutic management
T cells
Clinical Trials
Immunology
89Zr-
CD8
PET radiopharmaceuticals
Clinical development

Date founded

2007

Funding rounds raised

Total raised

$21M

from 6 investors over 6 rounds

I

ImaginAb raised $13M on June 3, 2021

Investors: Adage Capital Management

I

ImaginAb raised $8M on September 14, 2017

Investors: Adage Capital Management, Parker Institute for Cancer Immunotherapy and Nextech Invest

I

ImaginAb raised $21M on May 8, 2014

Investors: Nextech Invest

I

ImaginAb raised $13M on March 27, 2012

Investors: Momentum Bioscience Ltd

FAQ